BrainStorm Cell Therapeutics
BCLI
#10915
Rank
โ‚ฌ9.52 M
Marketcap
0,86ย โ‚ฌ
Share price
-4.04%
Change (1 day)
47.43%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2026 (TTM): -0,92ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -0,97ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -6,13ย โ‚ฌ an increase over its 2014 EPS that were of -9,27ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,92ย โ‚ฌ
2015-6,13ย โ‚ฌ-33.82%
2014-9,27ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
2,14ย โ‚ฌ-320.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,82ย โ‚ฌ 189.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,64ย โ‚ฌ 274.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,49ย โ‚ฌ 464.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
1,84ย โ‚ฌ-288.79%๐Ÿ‡บ๐Ÿ‡ธ USA